|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200065964 |
|
最近更新日期: Date of Last Refreshed on: |
2022-11-25 19:42:35 |
|
注册时间: Date of Registration: |
2022-11-20 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
“椎骨错缝”影像评价量表初稿的编制与优化 |
|
Public title: |
Compilation and optimization of the imaging evaluation scale for ''vertebral dislocation'' |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
“椎骨错缝”影像评价量表初稿的编制与优化 |
|
Scientific title: |
Compilation and optimization of the imaging evaluation scale for ''vertebral dislocation'' |
|
研究课题代号(代码): Study subject ID: |
CI2021A03308 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
ChiMCTR2200006799 |
|
申请注册联系人: |
韩雪 |
研究负责人: |
韩雪 |
|
Applicant: |
Xue Han |
Study leader: |
Xue Han |
|
申请注册联系人电话: Applicant telephone: |
18911528099 |
研究负责人电话:
Study leader's |
18911528099 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
hxmmc@126.com |
研究负责人电子邮件: Study leader's E-mail: |
hxmmc@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市朝阳区花家地街中国中医科学院望京医院 |
研究负责人通讯地址: |
北京市朝阳区花家地街中国中医科学院望京医院 |
|
Applicant address: |
Wangjing Hospital of Chinese Academy of Chinese Medicine,Huajiadi Street,Chaoyang District,Beijing |
Study leader's address: |
Wangjing Hospital of Chinese Academy of Chinese Medicine,Huajiadi Street,Chaoyang District,Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
100102 |
研究负责人邮政编码: Study leader's postcode: |
100102 |
|
申请人所在单位: |
中国中医科学院望京医院 |
||
|
Applicant's institution: |
Wangjing Hospital of Chinese Academy of Chinese Medicine |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
WJEC-KT-2022-022-P002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国中医科学院望京医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical ethics committee of Wangjing hospital, Chinese Academy of traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-05-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
中国中医科学院广安门医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Guanganmen Hospital of Chinese Academy of Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市西城区北线阁5号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 5, Beixiange, Xicheng District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国中医科学院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Chinese Academy of Chinese Medicine |
||||||||||||||||||||||
|
研究疾病: |
腰椎间盘突出症 |
||||||||||||||||||||||
|
Target disease: |
lumbar disc herniation |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
1、基于既往成果、文献分析、专家问卷等,提出脊柱病 “椎骨错缝”影像学评价要素的基本架构,遵循规范流程而编制临床运用简便、有效的评价量表。 2、基于临床病例接受脊柱手法治疗后的改善效果,分析量化表格评分对判断“椎骨错缝”及其纠正程度的敏感性、稳定性。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Based on previous results, literature analysis, expert questionnaires, etc., the basic framework of the imaging evaluation elements of spinal disease "vertebrae dislocation" is proposed, and a simple and effective evaluation scale for clinical use is prepared following a standardized process. 2. Based on the improvement effect of clinical cases after receiving spinal manipulation treatment, the sensitivity and stability of quantitative table score in judging "vertebral dislocation" . |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.符合腰椎间盘突出症诊断标准;2.CT或MRI显示单纯一个病变节段:L4-5突出;3.年龄35-55岁的中年人;4.发作时程≥2周的非急性期;5.触诊见:患椎棘突向左或右偏歪、患椎上下棘间隙宽窄不等、患椎棘突旁压痛或伴有下肢放射痛、患椎棘上韧带触之钝厚;6.查体见:下腰椎弧度、骶骨倾斜度、骨盆水平等出现腰骶部力学失衡改变;7.治疗前后均完成了站立位腰椎正侧位X线片的检查、以及仰卧位MR检查。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Meeting the diagnostic criteria for lumbar disc herniation; |
||||||||||||||||||||||
|
排除标准: |
1.腰椎间盘突出症与腰椎管狭窄症合并发病的患者;2.多个节段腰椎间盘突出症的患者;3.发作2周内神经根性疼痛明显、或行走困难的急性期患者;4.足下垂等腓总神经麻痹,或尿便障碍、鞍区麻木等马尾神经损伤的患者;5.合并椎体滑脱、强直性脊柱炎、代谢性骨病、骨质疏松、肿瘤、结核、骨折、感染等影响脊柱形态的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with lumbar disc herniation and lumbar spinal stenosis; 2. Patients with multiple segmental lumbar disc herniation; 3. Acute stage patients with obvious nerve root pain or difficulty in walking within 2 weeks after onset; 4. Patients with common peroneal nerve paralysis such as foot drop, or cauda equina nerve injury such as urinary and fecal disorders and numbness in sella region; 5. Patients with spondylolisthesis, ankylosing spondylitis, metabolic bone disease, osteoporosis, tumor, tuberculosis, fracture, infection and other factors that affect the shape of the spine. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-10-03 00:00:00至 To 2024-10-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-11-21 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
未使用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not used |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2024年12月ResMan共享数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Resman shared data in December 2024 |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
专门人员录入数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data entry by specialized personnel |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |